Newsletter - Update on M3 upgrade, AI Symposium, NeCTAR VLs have huge impact
Machine Learning Symposium; Update on M3 upgrade; NeCTAR Virtual Labs have huge impact.
NeCTAR Virtual Labs have huge impact
The Characterisation Virtual Laboratory (CVL) is one of the National eResearch Collaboration Tools and Resources (NeCTAR) supported Virtual Laboratories (VLs) covered by the new report "Estimating the value and impact of Nectar Virtual Laboratories" by the Victoria Institute of Strategic Economic Studies at Victoria University for NeCTAR. According to NeCTAR "the report has found that return on investment (ROI) is at least double the investment for every measure of each of the VLs studied, indicating the services have a significant economic and user impact" (https://nectar.org.au/vls-have-huge-economic-research-impact/). Read more about the report and the full report on the NeCTAR website.
Newsletter - MASSIVE M3 upgrade and M1 retirement news
We’d like to update you on a number of exciting changes to our MASSIVE systems and platforms.
Newsletter - NCMAS 2018, Deep Learning for Life Sciences Workshop and M3 Update
NCMAS 2018 Call for Applications; Deep Learning for Life Sciences Workshop; M3 Update
MASSIVE Research Stories: Making Sense of Drug Resistance in Pathogenic Bacteria
Around the world researchers are striving to find new ways to treat infections as antibiotics lose their ability to halt the spread of pathogenic bacteria.
Over time, the so-called 'superbugs' have developed resistance to the latest and until now the best antibiotics. Clearly, new approaches are needed to understand the process of antibiotic resistance and to design better drugs and treatments.
Monash researchers are making a major contribution to the push to eliminate superbugs. Among them, Dr Matt Belousoff, working together with Professor Trevor Lithgow, spends much of his time looking very closely at the structure of bacterial ribosomes, the molecular machines that make proteins and enable the bacteria to thrive.